Inrig Jula
Officer at TVTX
- Sold, on record
- $5.5M
- Dollars the filings state
- Form 4 sales
- 16
- Latest Sep 15, 2026
- Form 144 notices
- 14
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- TVTXTravere Therapeutics, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice TVTXNoticeApr 15, 2026 2026
Filed to sell 1,018 shares ($43k)
Inrig Jula, Officer
10b5-1 plan0.4x usual sizeFiling
- 2 Form 4 sale TVTXUnusualApr 15, 2026 same day
Sold 8,233 shares at $42.01 ($346k)
Inrig Jula, CHIEF MEDICAL OFFICER
10b5-1 planSold 6.9% of holdings ($5M position)111,473 shares left3.3x usual sizeFollows a Form 144Filing
- 3 Form 144 notice TVTXNoticeMay 4, 2026 +19 days
Filed to sell 20,000 shares ($900k)
Inrig Jula, Officer
10b5-1 plan8x usual sizeFiling
- 4 Form 144 notice TVTXNoticeMay 5, 2026 +1 day
Filed to sell 2,174 shares ($101k)
Inrig Jula, Officer
No 10b5-1 plan0.9x usual sizeFiling
- 5 Form 144 notice TVTXNoticeMay 6, 2026 +1 day
Filed to sell 311 shares ($14k)
Inrig Jula, Officer
10b5-1 plan0.1x usual sizeFiling
- 6 Form 4 sale TVTXUnusualMay 6, 2026 same day
Sold 22,485 shares at $45.15 ($1M)
Inrig Jula, CHIEF MEDICAL OFFICER
10b5-1 planSold 16.6% of holdings ($6.1M position)113,238 shares left9x usual sizeFollows a Form 144Filing
- 7 Form 144 notice TVTXNoticeSep 15, 2026 +132 days
Filed to sell 44,674 shares ($2.9M)
Inrig Jula, Officer
10b5-1 plan11.4x usual sizeFiling
- 8 Form 4 sale TVTXUnusualSep 15, 2026 same day
Sold 44,674 shares at $62.34 ($2.8M)
Inrig Jula, EVP, Head of R&D & CMO
10b5-1 planSold 30.8% of holdings ($9M position)100,491 shares left11.4x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (30)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Sep 17, 2026 | TVTX | EVP, Head of R&D & CMO | Form 4 sale | 44,674 | $2.8M | 30.8% | Unusual | SEC |
| Sep 15, 2026 | Sep 15, 2026 | TVTX | Officer | Form 144 notice | 44,674 | $2.9M | Notice | SEC | |
| May 6, 2026 | May 6, 2026 | TVTX | CHIEF MEDICAL OFFICER | Form 4 sale | 22,485 | $1M | 16.6% | Unusual | SEC |
| May 6, 2026 | May 6, 2026 | TVTX | Officer | Form 144 notice | 311 | $14k | Notice | SEC | |
| May 5, 2026 | May 5, 2026 | TVTX | Officer | Form 144 notice | 2,174 | $101k | Notice | SEC | |
| May 4, 2026 | May 4, 2026 | TVTX | Officer | Form 144 notice | 20,000 | $900k | Notice | SEC | |
| Apr 15, 2026 | Apr 15, 2026 | TVTX | CHIEF MEDICAL OFFICER | Form 4 sale | 8,233 | $346k | 6.9% | Unusual | SEC |
| Apr 15, 2026 | Apr 15, 2026 | TVTX | Officer | Form 144 notice | 1,018 | $43k | Notice | SEC | |
| Apr 14, 2026 | Apr 14, 2026 | TVTX | Officer | Form 144 notice | 7,215 | $303k | Notice | SEC | |
| Feb 4, 2026 | Feb 5, 2026 | TVTX | CHIEF MEDICAL OFFICER | Form 4 sale | 1,779 | $57k | 1.7% | Routine | SEC |
| Feb 4, 2026 | Feb 4, 2026 | TVTX | Officer | Form 144 notice | 1,779 | $57k | Notice | SEC | |
| Feb 3, 2026 | Feb 3, 2026 | TVTX | Officer | Form 144 notice | 6,956 | $223k | Notice | SEC | |
| Feb 3, 2026 | Feb 3, 2026 | TVTX | CHIEF MEDICAL OFFICER | Form 4 sale | 6,956 | $223k | 6.1% | No plan | SEC |
| Jan 6, 2026 | Jan 7, 2026 | TVTX | CHIEF MEDICAL OFFICER | Form 4 sale | 2,476 | $98k | 2.8% | Routine | SEC |
| Jan 6, 2026 | Jan 6, 2026 | TVTX | Officer | Form 144 notice | 445 | $17k | Notice | SEC | |
| Jan 5, 2026 | Jan 5, 2026 | TVTX | Officer | Form 144 notice | 2,031 | $82k | Notice | SEC | |
| Dec 29, 2025 | Dec 29, 2025 | TVTX | Officer | Form 144 notice | 15,000 | $630k | Notice | SEC | |
| Dec 24, 2025 | Dec 29, 2025 | TVTX | CHIEF MEDICAL OFFICER | Form 4 sale | 15,000 | $630k | 14.5% | Unusual | SEC |
| Jul 1, 2025 | Jul 2, 2025 | TVTX | CHIEF MEDICAL OFFICER | Form 4 sale | 815 | $12k | 0.9% | Routine | SEC |
| Feb 12, 2025 | Feb 12, 2025 | TVTX | Officer | Form 144 notice | 2,568 | $60k | Notice | SEC | |
| Feb 12, 2025 | Feb 12, 2025 | TVTX | CHIEF MEDICAL OFFICER | Form 4 sale | 2,568 | $60k | 2.8% | No plan | SEC |
| Feb 4, 2025 | Feb 4, 2025 | TVTX | Officer | Form 144 notice | 1,066 | $21k | Notice | SEC | |
| Feb 4, 2025 | Feb 4, 2025 | TVTX | CHIEF MEDICAL OFFICER | Form 4 sale | 5,273 | $106k | 5.9% | Routine | SEC |
| Feb 3, 2025 | Feb 3, 2025 | TVTX | Officer | Form 144 notice | 4,207 | $85k | Notice | SEC | |
| Jan 6, 2025 | Jan 6, 2025 | TVTX | CHIEF MEDICAL OFFICER | Form 4 sale | 2,506 | $48k | 4.0% | Routine | SEC |
| Sep 10, 2024 | Sep 10, 2024 | TVTX | CHIEF MEDICAL OFFICER | Form 4 sale | 684 | $9k | 1.1% | Routine | SEC |
| Sep 9, 2024 | Sep 9, 2024 | TVTX | CHIEF MEDICAL OFFICER | Form 4 sale | 2,191 | $25k | 3.4% | No plan | SEC |
| Feb 1, 2024 | Feb 2, 2024 | TVTX | CHIEF MEDICAL OFFICER | Form 4 sale | 2,174 | $19k | 3.6% | No plan | SEC |
| Jan 4, 2024 | Jan 5, 2024 | TVTX | Chief Medical Officer | Form 4 sale | 2,509 | $24k | 6.6% | No plan | SEC |
| Jan 5, 2023 | Jan 6, 2023 | TVTX | Chief Medical Officer | Form 4 sale | 2,493 | $52k | 12.5% | Plan not stated | SEC |